Active surveillance of men with prostate cancer has received increasing interest over the past decade, resulting in the publication of a wide range of different guidelines on the management of patients in active surveillance programmes, often with very different recommendations. Here, authors describe the various available guidelines and how they differ from each other, highlighting the need for an international consensus on the optimal use of active surveillance in patients with prostate cancer.
- Sophie M. Bruinsma
- Chris H. Bangma
- Liying Zhang
